Tactile Systems Technology (TCMD) Cash from Operations Growth (3y) (2018 - 2026)
Tactile Systems Technology (TCMD) Cash from Operations Growth (3y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | 4.78% |
| 2 | Stryker | 128.82 Bn | 125.94 Bn | 3.81 Bn | 9.30% |
| 3 | Medtronic | 108.74 Bn | 99.52 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 68.40 Bn | 66.95 Bn | 3.61 Bn | 22.35% |
| 5 | Edwards Lifesciences | 47.42 Bn | 43.74 Bn | 1.29 Bn | -48.14% |
| 6 | GE HealthCare Technologies | 28.47 Bn | 26.18 Bn | 1.98 Bn | -14.75% |
| 7 | Dexcom | 28.42 Bn | 27.30 Bn | 750.30 Mn | 50.11% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.52 Bn | 22.39 Bn | 2.07 Bn | 0.50% |
| 10 | Tactile Systems Technology | 630.13 Mn | 539.94 Mn | 57.61 Mn | 12.27% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.27% |
| Dec 31, 2025 | 64.93% |
| Sep 30, 2025 | 66.16% |
| Jun 30, 2025 | 85.66% |
| Mar 31, 2025 | 28.67% |
| Dec 31, 2024 | 42.83% |
| Sep 30, 2024 | 126.98% |
| Jun 30, 2024 | 139.66% |
| Mar 31, 2024 | 46.67% |
| Dec 31, 2023 | 53.86% |
| Sep 30, 2023 | -10.61% |
| Jun 30, 2023 | 52.76% |
| Mar 31, 2023 | -36.66% |
| Dec 31, 2022 | 251.19% |
| Sep 30, 2022 | 12.81% |
| Jun 30, 2022 | 95.43% |
| Mar 31, 2022 | -65.32% |
| Dec 31, 2021 | 1.74% |
| Sep 30, 2021 | -30.22% |
| Jun 30, 2021 | -51.00% |